Comparing liver biopsy and fibroscan for liver donors
Part of Digestive system clinical trials.
This study compares two ways to check the health of a donor's liver before a transplant: a traditional liver biopsy (taking a small sample) and a non-invasive scan called FibroScan. It aims to see if the scan can replace the biopsy, making the process easier and safer for donors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be a potential liver donor for a transplant.
- You must agree to have a FibroScan test, which is a painless scan to check your liver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to use a FibroScan (a non-invasive liver scanner) with a single probe to measure liver health in people with chronic liver disease. If you have a long-term liver condition, this trial may help improve how liver exams are done.
This study is looking for new ways to detect liver scarring (fibrosis) in people with fatty liver disease (NAFLD, NASH, MASLD, or MASH). If you qualify, you will give a blood sample to help identify biomarkers that could replace biopsies.
This study uses a special ultrasound during an endoscopic procedure to measure liver stiffness and fat, and compares it to a standard FibroScan. It aims to see if the new method works as well for people with normal liver health.
This study tests a new, non-invasive way to measure liver stiffness using a device called FibroScan. It aims to make liver checkups easier and more comfortable for people with liver disease.
This trial uses a blood test (FIB-4) to find liver scarring (fibrosis) in people who haven't been tested before. It aims to catch advanced liver disease early, which can help you get treatment sooner.
This trial uses a special ultrasound (Fibroscan) to check your liver health and see if you can safely reduce your anti-rejection medications. It is for people who are at least 2 years past a liver transplant and whose liver is working well.
Hear when a new Non-invasive Donor Liver Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.